TSND Stock Overview
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
TerrAscend Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$2.29 |
| 52 Week High | CA$3.21 |
| 52 Week Low | CA$1.72 |
| Beta | 1.98 |
| 1 Month Change | -2.55% |
| 3 Month Change | -19.65% |
| 1 Year Change | 10.63% |
| 3 Year Change | -83.26% |
| 5 Year Change | -72.41% |
| Change since IPO | 89.26% |
Recent News & Updates
Recent updates
What You Can Learn From TerrAscend Corp.'s (TSE:TSND) P/SAfter Its 25% Share Price Crash
Mar 10
Revenues Tell The Story For TerrAscend Corp. (TSE:TSND) As Its Stock Soars 25%
Jan 24Is TerrAscend (TSE:TSND) A Risky Investment?
Dec 25TerrAscend (TSE:TSND) Is Carrying A Fair Bit Of Debt
Aug 13TerrAscend Corp.'s (CSE:TER) Earnings Haven't Escaped The Attention Of Investors
Jul 03TerrAscend (CSE:TER) Is Making Moderate Use Of Debt
Mar 06Is There An Opportunity With TerrAscend Corp.'s (CSE:TER) 37% Undervaluation?
Dec 21Some Analysts Just Cut Their TerrAscend Corp. (CSE:TER) Estimates
Aug 14Is TerrAscend (CSE:TER) Using Too Much Debt?
Jul 15Is TerrAscend (CSE:TER) Using Too Much Debt?
Nov 03Time To Worry? Analysts Just Downgraded Their TerrAscend Corp. (CSE:TER) Outlook
Aug 21Does TerrAscend (CSE:TER) Have A Healthy Balance Sheet?
Jun 16Shareholder Returns
| TSND | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -8.0% | -3.9% | 1.2% |
| 1Y | 10.6% | 53.0% | 6.1% |
Return vs Industry: TSND underperformed the Canadian Pharmaceuticals industry which returned 53% over the past year.
Return vs Market: TSND exceeded the Canadian Market which returned 6.1% over the past year.
Price Volatility
| TSND volatility | |
|---|---|
| TSND Average Weekly Movement | 10.6% |
| Pharmaceuticals Industry Average Movement | 13.8% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: TSND's share price has been volatile over the past 3 months.
Volatility Over Time: TSND's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | 1,055 | Ziad Ghanem | www.terrascend.com |
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.
TerrAscend Corp. Fundamentals Summary
| TSND fundamental statistics | |
|---|---|
| Market cap | CA$812.38m |
| Earnings (TTM) | -CA$124.45m |
| Revenue (TTM) | CA$433.50m |
1.5x
P/S Ratio-5.4x
P/E RatioIs TSND overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TSND income statement (TTM) | |
|---|---|
| Revenue | US$317.33m |
| Cost of Revenue | US$157.63m |
| Gross Profit | US$159.70m |
| Other Expenses | US$250.80m |
| Earnings | -US$91.10m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | -0.31 |
| Gross Margin | 50.33% |
| Net Profit Margin | -28.71% |
| Debt/Equity Ratio | 85.8% |
How did TSND perform over the long term?
See historical performance and comparison